Pennsylvania Department of Public Welfare
Public Testimony
At the entrance to the meeting room, a sign-in sheet will be provided and any representatives from the public are invited to sign in and attend. Seating will be permitted on a first-come basis, not to exceed the seating capacity of the room.
Registration:
- The registration for testimony must be received at least fourteen (14) days before the meeting. The registration form is interactive and when submitted will go directly to the Committee Chairperson.
- Registration will occur on a first-come, first-serve basis.
- The registered speaker must identify the drug that will be the subject of the testimony as part of registration.
- Registrants who prefer to provide testimony in writing only may do so and will be instructed to bring hard copies of the written testimony to the meeting for distribution to all P&T Committee members.
- Manufacturers that produce products in multiple drug classes may register to testify on each class of drugs.
- Only one manufacturer representative can testify (orally or in writing) per product. If more than one manufacturer representative registers for testimony on the same product, the first registered will be allowed to testify or present written testimony and the other(s) will be declined.
Procedures:
- At meeting sign-in, registered speakers will be informed of the recommended designation of the drug that they are interested in and given the opportunity to defer testimony when the recommendation is “preferred.”
- Reviews will be completed on a class by class basis.
- After an overview of the drug monograph for a specific class of drugs, registered speakers who did not defer their testimony will testify.
- If the final vote of the P&T Committee is different from the original recommendation and the final recommendation is “non-preferred,” registered speakers who deferred testimony will be given the opportunity to provide their testimony.
Guidelines
- Each testimony will be a maximum of two (2) minutes long.
- Each speaker must share their name, title, organization, city of business and disclose if a drug manufacturer requested them to appear and testify in a paid or unpaid capacity. Written testimony must also include this information.
- Each speaker must provide a hard copy of the testimony at meeting sign-in and may distribute copies to the P&T Committee members at the time of testimony. Copies of written testimony should also be provided at meeting sign-in.
- Materials will be restricted to one (1), 8½ X 11 inch, single-sided page of bulleted information.
- No audio-visual equipment can be used.
- There will be no question and answer period.
- No clinical submissions by manufacturers, companies, or organizations such as, but not limited to, package inserts, will be accepted in advance of the meeting for inclusion in the P&T Committee members’ information packets or distributed during the meeting.
After reviewing the above criteria, please proceed to the Registration For Testimony page to submit your request.
Back to the Pennsylvania Medicaid page.